Filing Details
- Accession Number:
- 0001140361-14-012346
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-12 15:09:48
- Reporting Period:
- 2014-03-11
- Filing Date:
- 2014-03-12
- Accepted Time:
- 2014-03-12 15:09:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1514588 | Adam Havey | 2273 Research Blvd. Suite 400 Rockville MD 20853 | Evp, Biodefense Divison | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-03-11 | 1,336 | $28.09 | 28,695 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2014-03-11 | 14,060 | $0.00 | 42,755 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2014-03-11 | 5,835 | $26.96 | 36,920 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-03-11 | 4,887 | $15.83 | 41,807 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-03-11 | 6,933 | $15.91 | 48,800 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-11 | 11,820 | $26.96 | 36,920 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2014-03-11 | 28,119 | $0.00 | 28,119 | $28.09 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-03-11 | 6,933 | $0.00 | 6,933 | $15.91 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-03-11 | 4,887 | $0.00 | 4,887 | $15.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,119 | 2021-03-10 | No | 4 | A | Direct | |
| 0 | 2014-03-08 | No | 4 | M | Direct | |
| 4,887 | 2019-03-12 | No | 4 | M | Direct |
Footnotes
- Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
- These restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- Vests in three equal installments on March 10, 2015, March 10, 2016 and March 10, 2017.
- The option is fully vested.
- The option will vest with respect to the remaining 4,887 shares on March 12, 2015.
Billionaire Hedge Funds
